Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Inventory Average: 2022-2025

Historic Inventory Average for Mirum Pharmaceuticals (MIRM) over the last 4 years, with Sep 2025 value amounting to $23.5 million.

  • Mirum Pharmaceuticals' Inventory Average rose 11.73% to $23.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.5 million, marking a year-over-year increase of 11.73%. This contributed to the annual value of $22.4 million for FY2024, which is 60.40% up from last year.
  • As of Q3 2025, Mirum Pharmaceuticals' Inventory Average stood at $23.5 million, which was up 3.53% from $22.7 million recorded in Q2 2025.
  • Mirum Pharmaceuticals' Inventory Average's 5-year high stood at $23.5 million during Q3 2025, with a 5-year trough of $1.5 million in Q1 2022.
  • For the 3-year period, Mirum Pharmaceuticals' Inventory Average averaged around $18.7 million, with its median value being $22.0 million (2024).
  • As far as peak fluctuations go, Mirum Pharmaceuticals' Inventory Average soared by 293.73% in 2023, and later decreased by 1.27% in 2024.
  • Mirum Pharmaceuticals' Inventory Average (Quarterly) stood at $6.3 million in 2022, then spiked by 256.27% to $22.3 million in 2023, then fell by 1.27% to $22.0 million in 2024, then climbed by 11.73% to $23.5 million in 2025.
  • Its last three reported values are $23.5 million in Q3 2025, $22.7 million for Q2 2025, and $22.4 million during Q1 2025.